ALLO vs EXPD · rev $22.0K vs P/E 26, rev $10.60B
Allogene Therapeutics Inc (ALLO) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
ALLO currently screens at market cap $258.1M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the ALLO and EXPD stock pages for the full models.
Not investment advice.